GW PHARMACEUTICALS PLC Deferred Tax Assets, Net of Valuation Allowance
GW PHARMACEUTICALS PLC had Deferred Tax Assets, Net of Valuation Allowance of $23.19 million as of 2020-12-31, per its 10-K filed 2021-02-26.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2021-02-26
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $23.19M.
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $19.75M.
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $9.95M.
- 2018-09-30: Deferred Tax Assets, Net of Valuation Allowance $8.64M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2020-12-31 | $23.19M 10-K · filed 2021-02-26 |
| 2019-12-31 | $19.75M 10-K · filed 2021-02-26 |
| 2018-12-31 | $9.95M 10-K · filed 2020-02-27 |
| 2018-09-30 | $8.64M 10-K · filed 2020-02-27 |
| 2017-09-30 | $10.24M 10-K · filed 2020-02-27 |